Last year @doctoranita wrote a commentary entitled "Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?" 11/16 https://t.co/PYd7TylTO0

Will #COVID19 be the tipping point for primary #HPV self-sampling? Evidence shows that self-sampling is not inferior to clinician-taken samples and can be done socially distanced. Read the commentary by Anita Wey Wey Lim here. @KCLcancer_pharm https://t.c

Will #COVID19 be the tipping point for primary #HPV self-sampling? Evidence shows that self-sampling is not inferior to clinician-taken samples and can be done socially distanced. Read the commentary by Anita Wey Wey Lim here. @KCLcancer_pharm https://t.c

New article: Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? https://t.co/25wqZ4l5eB #uterinecancer #oncology https://t.co/hjC1sKruCl

Will #COVID-19 be the tipping point for primary #HPV self-sampling? Evidence shows that self-sampling is not inferior to clinician-taken samples and can be done socially distanced. Read the commentary by Anita Wey Wey Lim @KCLcancer_pharm: https://t.co/Bq